Michiana Hematology-Oncology, PC - South Bend — Mishawaka, Indiana

Michiana Hematology-Oncology, PC - South Bend is a clinical research site located in Mishawaka, Indiana, United States 46545-1470.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Michiana Hematology-Oncology, PC - South Bend has participated in 40 clinical trials with 4 currently active.

Therapeutic areas: Breast Cancer, Cancer Survivor, Hot Flashes.

Sponsors: Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mishawaka

Browse all research sites in Indiana · View every site in Mishawaka

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michiana Hematology-Oncology, PC - South Bend?

Michiana Hematology-Oncology, PC - South Bend has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michiana Hematology-Oncology, PC - South Bend conducted?

Michiana Hematology-Oncology, PC - South Bend has 40 clinical trials on record, with 4 currently active. Their work covers Breast Cancer, Cancer Survivor, Hot Flashes.

Is Michiana Hematology-Oncology, PC - South Bend accredited by Crixeo Clinical Trials?

Michiana Hematology-Oncology, PC - South Bend has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michiana Hematology-Oncology, PC - South Bend?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.